| |
| |
|
| Insider
Information: |
Doyle Anthony |
| Relationship: |
Chief Financial Officer |
| City: |
Durham |
| State: |
NC |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
1 |
|
| Direct
Shares |
227,444 |
|
|
Indirect Shares
|
0 |
|
|
| Direct
Value |
$1,018,949 |
|
|
|
Indirect Value
|
$0 |
|
|
| Total
Shares |
227,444 |
|
|
| Total
Value |
$1,018,949 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
0
|
|
Stock
price went up :
|
|
|
| Stock
price went down : |
|
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
| Percentage
Gain/Loss : |
0.0%
|
0.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Biocryst Pharmaceuticals Inc |
BCRX |
Chief Financial Officer |
2023-12-19 |
227,444 |
2020-08-11 |
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
8 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 1 of 1
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| BCRX |
Biocryst Pharmaceuticals ... |
Chief Financial Officer |
• • – |
2023-12-19 |
4 |
D |
$6.05 |
$15,016 |
D/D |
(2,482) |
227,444 |
0 |
- |
|
| BCRX |
Biocryst Pharmaceuticals ... |
Chief Financial Officer |
• • – |
2023-12-14 |
4 |
A |
$0.00 |
$0 |
D/D |
34,000 |
235,401 |
0 |
- |
|
| BCRX |
Biocryst Pharmaceuticals ... |
Chief Financial Officer |
• • – |
2023-12-14 |
4 |
D |
$6.43 |
$35,204 |
D/D |
(5,475) |
229,926 |
0 |
- |
|
| BCRX |
Biocryst Pharmaceuticals ... |
Chief Financial Officer |
• • – |
2022-12-19 |
4 |
A |
$0.00 |
$0 |
D/D |
34,000 |
197,966 |
0 |
- |
|
| BCRX |
Biocryst Pharmaceuticals ... |
Chief Financial Officer |
• • – |
2022-12-15 |
4 |
AS |
$10.90 |
$62,130 |
D/D |
(5,700) |
163,966 |
0 |
% |
|
| BCRX |
Biocryst Pharmaceuticals ... |
Chief Financial Officer |
• • – |
2021-12-14 |
4 |
A |
$0.00 |
$0 |
D/D |
115,000 |
208,719 |
0 |
- |
|
| BCRX |
Biocryst Pharmaceuticals ... |
Chief Financial Officer |
• • – |
2021-12-14 |
4/A |
A |
$0.00 |
$0 |
D/D |
75,000 |
168,719 |
0 |
- |
|
| BCRX |
Biocryst Pharmaceuticals ... |
Chief Financial Officer |
• • – |
2020-08-11 |
4 |
B |
$4.08 |
$220,320 |
D/D |
54,000 |
54,000 |
2.74 |
% |
|
8 Records found
|
1
|
Page 1 of 1 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
